Tesamorelin 10mg

99% Purity Lyophilized Peptide Powder

CA$90.00

Out of stock

Tesamorelin is a precision-engineered Growth Hormone Releasing Hormone (GHRH) analogue designed to stimulate the body's natural growth hormone production while preserving normal hormonal feedback mechanisms. Unlike exogenous growth hormone, Tesamorelin promotes physiologic GH release, resulting in increased IGF-1 levels without suppressing endogenous hormone production.

Clinical research has demonstrated that Tesamorelin selectively reduces visceral adipose tissue (VAT)—the metabolically active fat surrounding internal organs—while largely preserving subcutaneous fat. Studies have reported reductions in visceral fat of 15–20% over six months, making it one of the most extensively studied peptides for body composition and metabolic health.

Beyond fat reduction, emerging research suggests Tesamorelin may support cognitive function, mitochondrial health, and neuroprotection through GH and IGF-1 signaling. With its targeted mechanism of action and decades of clinical investigation, Tesamorelin remains a leading peptide in metabolic, longevity, and regenerative medicine research.

Ships from Canada for fast and reliable domestic fulfillment.

Safety & Considerations

Tesamorelin is generally well tolerated; however, the most commonly reported adverse effects include injection site reactions, mild joint or muscle discomfort, fluid retention, and occasional tingling or numbness in the hands or fingers.

Less commonly, some individuals may experience mild elevations in fasting blood glucose, headache, dizziness, palpitations, or sleep disturbances. Hypersensitivity reactions, including rash or swelling, have also been reported and warrant discontinuation if they occur.

Tesamorelin should not be used during pregnancy and should be avoided in individuals with active malignancy due to its effects on the growth hormone/IGF-1 axis. Individuals with diabetes or insulin resistance should monitor blood glucose closely during treatment, and concurrent use with exogenous growth hormone or IGF-1 therapies should only occur under appropriate medical supervision.